US Patent 8993556 Resorcinol derivatives as HSP90 inhibitors
Patent 8993556 was granted and assigned to Nerviano Medical Sciences on March, 2015 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 8993556 Resorcinol derivatives as HSP90 inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
